Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of MenAC Conjugate Vaccine in Infants
NCT06314659Phase 3Active, not recruiting
- Sponsor
- Zhifei Green Bamboo
- Start
- Sep 2021
- Primary completion
- Dec 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Meningococcal Group A and C Polysaccharide Conjugate Vaccine in meningococcal disease, sponsored by Zhifei Green Bamboo. Started Sep 2021; status: active, not recruiting.
02
Drugs
Meningococcal Group A and C Polysaccharide Conjugate Vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT06314659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06314659.